SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001636050-22-000054
Filing Date
2022-12-14
Accepted
2022-12-14 16:04:59
Documents
15
Period of Report
2022-12-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K siox-20221214.htm   iXBRL 8-K 47207
2 EX-2.1 exhibit21-12142022.htm EX-2.1 44438
3 EX-99.1 exhibit991-12142022.htm EX-99.1 13971
  Complete submission text file 0001636050-22-000054.txt   303855

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20221214.xsd EX-101.SCH 2151
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20221214_def.xml EX-101.DEF 15774
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20221214_lab.xml EX-101.LAB 30943
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20221214_pre.xml EX-101.PRE 16487
9 EXTRACTED XBRL INSTANCE DOCUMENT siox-20221214_htm.xml XML 15018
Mailing Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036
Business Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 221462146
SIC: 2834 Pharmaceutical Preparations